The Patent Finder

Arena Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Arena Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 113 patents it holds.

Back to Arena Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,780,827Substituted 3-Phenoxyazetidin-1-YL-PYRAZINES
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,115,1573-Phenoxyazetidin-1-YL-HETEROARYL Pyrrolidine Derivatives and the Use Thereof as Medicament
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,802,845Processes for the Preparation of 8-Chloro-1-Methyl-2,3,4,5-Tetrahydro-1H-3-Benzazepine and Intermediates Related Thereto
Lapsed on the fee record
Ended Aug 12, 2026 · High confidence
Lapsed on the fee recordEnded Aug 12, 2026High confidence
US 8,754,238Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
Lapsed on the fee record
Ended Jun 17, 2026 · USPTO record
Lapsed on the fee recordEnded Jun 17, 2026USPTO record
US 8,980,881Crystalline Forms of (R)-8-Chloro-1-Methyl-2,3,4,5-Tetrahydro-1H-3-Benzazepine Hydrochloride
Term ended
Ended no later than Apr 9, 2026 · Low confidence
Term endedEnded no later than Apr 9, 2026Low confidence
US 9,867,822Cannabinoid receptor modulators
Lapsed on the fee record
Ended Jan 16, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 16, 2026USPTO record
US 7,241,792Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
Term ended
Term ended Dec 29, 2025 · USPTO record
Term endedTerm ended Dec 29, 2025USPTO record
US 8,697,686Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-thtrahydro-1H-3-benzazepine hydrochloride
Term ended
Ended no later than Dec 20, 2025 · USPTO record
Term endedEnded no later than Dec 20, 2025USPTO record
US 7,884,1013-Phenyl-PYRAZOLE Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Treatment of Disorders Related Thereto
Term ended
Term ended Dec 8, 2025 · High confidence
Term endedTerm ended Dec 8, 2025High confidence
US 8,785,4413-Phenyl-PYRAZOLE Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Treatment of Disorders Related Thereto
Term ended
Term ended Nov 17, 2025 · High confidence
Term endedTerm ended Nov 17, 2025High confidence
10 of 110 patents shown.
Pro members see all 110.
Pro members: see all 110 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited